Christopher Alfonso

Title: Inventor Spotlight: Christopher Alfonso

Introduction

Christopher Alfonso, a prominent inventor based in San Diego, CA, has made significant contributions to the field of biotechnology. With one patent to his name, he has focused on innovative methods that enhance the production of B cells and antibodies, which are crucial for various medical applications.

Latest Patents

Christopher Alfonso's patented invention, titled "Methods for Producing B cells and antibodies from H2-O modified transgenic mice," presents a groundbreaking approach in the realm of transgenic technology. The patent describes a method for creating a transgenic animal through the introduction of an altered H2-O gene. The resulting animals exhibit a significantly higher frequency of high-affinity antibodies compared to H2-O wild-type animals. This advancement has the potential to facilitate the production of these valuable antibodies for therapeutic purposes.

Career Highlights

Currently, Christopher is employed at Ortho-McNeil Pharmaceutical Corporation, where he continues to leverage his expertise in biotechnology to drive innovation. His work demonstrates a commitment to improving medical research through advanced genetic techniques.

Collaborations

Throughout his career, Christopher has collaborated with esteemed colleagues, including Lars Karlsson and Wai-Ping Leung. Their collective efforts in research and development have further enhanced the impact of their discoveries in the field.

Conclusion

Christopher Alfonso's contributions to biotechnology and transgenic research highlight the importance of innovation in developing new medical solutions. His patent emphasizes the potential of modified organisms in producing essential antibodies, showcasing his role as a significant figure in the landscape of modern science and pharmaceutical development.